首页|期刊导航|眼科学报(英文版)|Approved pharmacotherapy for myopic choroidal neovascularization: a review of randomized controlled trials in ranibizumab and aflibercept

Approved pharmacotherapy for myopic choroidal neovascularization: a review of randomized controlled trials in ranibizumab and afliberceptOA

Approved pharmacotherapy for myopic choroidal neovascularization: a review of randomized controlled trials in ranibizumab and aflibercept

Jia-Kang Wang;Tzu-Lun Huang;Pei-Yuan Su;Pei-Yao Chang

Department of Ophthalmology, Far Eastern Memorial Hospital, New Taipei, Taiwan, ChinaDepartment of Medicine, National Yang Ming University, Taipei, Taiwan, ChinaDepartment of Healthcare Administration,Oriental Institute of Technology, New Taipei, Taiwan, ChinaDepartment of Nursing, Oriental Institute of Technology, New Taipei, Taiwan, China

Intravitreal injectionafliberceptranibizumabmyopic choroidal neovascularization (mCNV)

Intravitreal injectionafliberceptranibizumabmyopic choroidal neovascularization (mCNV)

《眼科学报(英文版)》 2015 (4)

198-200,3

10.3978/j.issn.1000-4432.2015.11.05

评论

您当前未登录!去登录点击加载更多...